J&J said it “thanks Dr. Mammen for his contributions” and that William Hait, MD, PhD, will serve as the interim replacement for Dr. Mammen, who held the role for five years.
Before joining J&J, Dr. Mammen worked in executive roles at several pharmaceutical research and development companies, including Merck, Theravance Biopharma, Innoviva and Theravance, according to his LinkedIn profile.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
